Guided Therapeutics (GTHP) Amortizatization of Intangibles (2015 - 2022)
Guided Therapeutics (GTHP) reported Amortizatization of Intangibles of $50000.0 for Q3 2022, down 13.79% on a YoY basis from $58000.0 in Q3 2021, and up 412.5% sequentially from -$16000.0 in Q2 2022.
Guided Therapeutics (GTHP) Amortizatization of Intangibles (2015 - 2022) Analysis & Trends
Guided Therapeutics (GTHP) has 7 years of Amortizatization of Intangibles data on file, last reported at $50000.0 in Q3 2022.
- For the quarter ending Q3 2022, Amortizatization of Intangibles fell 13.79% year-over-year to $50000.0; the trailing twelve-month figure through Sep 2022 stood at -$8000.0 (up 33.33% YoY), and the FY2021 full-year result was $8000.0, changed N/A from the prior year.
- Amortizatization of Intangibles climbed to $50000.0 in Q3 2022, from -$16000.0 in the prior quarter.
- In the past five years, Amortizatization of Intangibles ranged from a high of $58000.0 in Q3 2021 to a low of -$78000.0 in Q4 2020.
- A 4-year average of $10714.3 and a median of $19000.0 in 2019 frame the typical range for Amortizatization of Intangibles.
- Across the five-year window, Amortizatization of Intangibles plunged 510.53% in 2020 and jumped 132.0% in 2021, its largest moves.
- Tracing GTHP's Amortizatization of Intangibles over 4 years: stood at $19000.0 in 2019, then sank by 510.53% to -$78000.0 in 2020, then advanced by 25.64% to -$58000.0 in 2021, then soared by 186.21% to $50000.0 in 2022.
- Business Quant data shows GTHP's Amortizatization of Intangibles at $50000.0 in Q3 2022, -$16000.0 in Q2 2022, and $16000.0 in Q1 2022.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 182.32 Bn | 175.02 Bn | 6.27 Bn | - |
| 2 | Stryker | 128.75 Bn | 125.88 Bn | 3.81 Bn | - |
| 3 | Medtronic | 107.83 Bn | 98.61 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 67.61 Bn | 66.15 Bn | 3.61 Bn | - |
| 5 | Edwards Lifesciences | 48.13 Bn | 44.45 Bn | 1.29 Bn | - |
| 6 | Dexcom | 28.26 Bn | 27.14 Bn | 750.30 Mn | - |
| 7 | GE HealthCare Technologies | 27.78 Bn | 25.50 Bn | 1.98 Bn | - |
| 8 | Smith & Nephew | 26.99 Bn | 26.41 Bn | - | - |
| 9 | Koninklijke Philips | 23.92 Bn | 20.80 Bn | 2.07 Bn | - |
| 10 | Guided Therapeutics | 20.78 Mn | 20.72 Mn | 458,000.00 | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2022 | 50,000.00 |
| Sep 30, 2022 | 50,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Jun 30, 2022 | -16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Mar 31, 2022 | 16,000.00 |
| Dec 31, 2021 | -58,000.00 |
| Dec 31, 2021 | -58,000.00 |
| Sep 30, 2021 | 58,000.00 |
| Sep 30, 2021 | 58,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Jun 30, 2021 | 8,000.00 |
| Dec 31, 2020 | -78,000.00 |
| Dec 31, 2020 | -78,000.00 |
| Sep 30, 2020 | 25,000.00 |
| Sep 30, 2020 | 25,000.00 |
| Jun 30, 2020 | 34,000.00 |
| Jun 30, 2020 | 34,000.00 |
| Mar 31, 2020 | 19,000.00 |
| Mar 31, 2020 | 19,000.00 |